By Brian-Admin
UPDATE:
The FDA did in fact issue an EUA on the Jynneos monkeypox vaccine on August 9th:
With a looming crisis of widespread contagion, the FDA announced on August 9 that rather than the prescribed two-shot dosage, the agency has issued an emergency use authorization (EUA) for the JYNNEOS vaccine to allow healthcare providers to use the vaccine by intradermal injection for individuals 18 years of age and older who are determined to be at high risk for monkeypox infection. (Source.)
Source: Health Impact News
- Rating:
- Views:204 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr